Browsing Category

65315 posts
Helical Fusion Achieves Breakthrough in Fusion Energy with Advanced Superconductor Test

Helical Fusion Achieves Breakthrough in Fusion Energy with Advanced Superconductor Test

Japanese innovator, Helical Fusion, pioneers high-current-density superconductor technology, setting a new benchmark…
STRADVISION Surpasses 1 Million Units in Annual Production, Leading the Charge in Automotive Vision Technology

STRADVISION Surpasses 1 Million Units in Annual Production, Leading the Charge in Automotive Vision Technology

SEOUL, South Korea, Feb. 27, 2024 /PRNewswire/ — Building on the success…
Frost & Sullivan Opens Nominations for Itron Excellence in Resourcefulness Awards

Frost & Sullivan Opens Nominations for Itron Excellence in Resourcefulness Awards

Utility and city industry participants elevating customer experience through technology-driven operational efficiency…
CGTN: CGTN polls on China's economy III: The next 'China' is still China!

CGTN: CGTN polls on China's economy III: The next 'China' is still China!

BEIJING, Feb. 26, 2024 /PRNewswire/ — "The next ‘China’ is still China!"…
Orange Business and Cisco sign first-of-its-kind MoU to accelerate GHG emissions reduction and support net zero goals

Orange Business and Cisco sign first-of-its-kind MoU to accelerate GHG emissions reduction and support net zero goals

Companies form collaborative partnership to accelerate progress towards GHG emission reduction goals.…
Group-IB Earns Frost & Sullivan's 2024 Competitive Strategy Leadership Award for Pioneering a Decentralized Approach in the External Risk Mitigation and Management Industry

Group-IB Earns Frost & Sullivan's 2024 Competitive Strategy Leadership Award for Pioneering a Decentralized Approach in the External Risk Mitigation and Management Industry

Group-IB has been at the forefront of the global fight against cybercrime…
MWC 2024: Auden Pushes into Ever Higher Frequencies in Journey to 6G

MWC 2024: Auden Pushes into Ever Higher Frequencies in Journey to 6G

State-of-the-art new millimeter wave antenna technologies expand Beyond 5G capabilities in FR2…
BioCity Announces Enrollment Completion of the IgA Nephropathy (IgAN) Cohort in the Randomized, Placebo-controlled Phase II Clinical Trial of the ETA Receptor Antagonist SC0062

BioCity Announces Enrollment Completion of the IgA Nephropathy (IgAN) Cohort in the Randomized, Placebo-controlled Phase II Clinical Trial of the ETA Receptor Antagonist SC0062

WUXI, China, Feb. 25, 2024 /PRNewswire/ — BioCity Biopharma is pleased to announce…